Table 2 HHV-8, CMV and EBV seropositivity according to age and gender among the 250 HIV-AIDS patients in Ghana
From: Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa
Age group, years | Proportion (%) of HIV-AIDS patients with HHV8 seropositivity | Proportion (%) of HIV-AIDS patients with CMV seropositivity | Proportion (%) of HIV-AIDS patients with EBV seropositivity | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Â | Men | Women | All | Men | Women | All | Men | Women | All |
16–25 | 11/18 (61.1) | 13/19 (68.4) | 24/37 (64.9) | 12/18 (66.7) | 10/19 (52.6) | 22/37 (59.5) | 16/18 (88.9) | 14/19 (73.7) | 30/37 (81.1) |
26–35 | 36/49 (73.5) | 29/41 (70.7) | 65/90 (72.2) | 31/49 (63.3) | 28/41 (68.3) | 59/90 (65.6) | 45/49 (91.8) | 35/41 (85.4) | 80/90 (88.9) |
36–45 | 24/38 (63.2) | 21/35 (60.0) | 45/73 (61.6) | 22/38 (57.9) | 19/35 (54.3) | 41/73 (56.2) | 35/38 (92.1) | 30/35 (85.7) | 65/73 (89.0) |
46–55 | 12/20 (60.0) | 9/16(56.3) | 21/36 (58.3) | 10/20 (50.0) | 8/16 (50.0) | 18/36 (50.0) | 17/20 (85.0) | 14/16 (87.5) | 31/36 (86.1) |
56–65 | 5/8 (62.5) | 4/6 (66.7) | 9/14 (64.3) | 5/8 (62.5) | 3/6 (50.0) | 8/14 (57.1) | 7/8 (87.5) | 5/6 (83.3) | 12/14 (85.7) |
Total | 88/140 (62.9) | 76/110 (69.1) | 164/250 (65.6) | 80/140 (57.1) | 68/110 (61.8) | 148/250 (59.2) | 122/140 (87.1) | 96/110 (87.3) | 218/250 (87.2) |